Efficacy of Reboxetin in childhood and adolescence with ADHD and Anxiety disorder in out-patient clinic
Not Applicable
- Conditions
- Attention deficit disorder with hyperactivity and anxity.F90, F93
- Registration Number
- IRCT138905033979N3
- Lead Sponsor
- Reserch Devision, Ahvaz Jondishapoor Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
ADHD and Anxeity disorder except for OCD and PTSD
Exclusion criteria: MR, presence of any medical problems, other psychotic disorder, drug or substance use
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Attention deficit hyperactivity disorder. Timepoint: at the beginning (baseline) and the end of second and fourth weeks of the study. Method of measurement: The Conner's parent rating scale–revised short version [CPRS –R(S)] scores.;Anxiety. Timepoint: At the beginning (baseline) and the end of second and fourth weeks of the study. Method of measurement: The Hamilton anxiety rating scale scores.
- Secondary Outcome Measures
Name Time Method Rate of diastolic and systolic blood pressure. Timepoint: at the beginning (baseline) and the end of second and fourth weeks of the study. Method of measurement: Assessment of peripheral blood pressure with blood pressure monitor.;Rate of side effects. Timepoint: at the beginning (baseline) and the end of second and fourth weeks of the study. Method of measurement: based on Pharmaceutical list.;Pulse rate. Timepoint: at the beginning (baseline) and the end of second and fourth weeks of the study. Method of measurement: Assessment of Peripheral pulse rate.